# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA302625 | 11 | IC50 | = | 269000 | nM | ALA3705870 | 321711 | nM | Homo sapiens | ||
2. | ALA302625 | 11 | Activity | = | 66 | % | ALA5257008 | % | Plasmodium berghei | |||
3. | ALA302625 | 11 | Activity | = | 54 | % | ALA5257006 | % | Plasmodium berghei | |||
4. | ALA302625 | 11 | Activity | 0 | ALA5257003 | Non-Toxic | ||||||
5. | ALA302625 | 11 | Activity | 0 | ALA5257002 | Non-Toxic | ||||||
6. | ALA302625 | 11 | Activity | > | 95 | % | ALA5257001 | % | ||||
7. | ALA302625 | 11 | Activity | 0 | ALA5257000 | Non-Toxic | ||||||
8. | ALA302625 | 11 | Activity | 0 | ALA5256999 | Toxic | ||||||
9. | ALA302625 | 11 | Activity | = | 20 | % | ALA5256998 | % | ||||
10. | ALA302625 | 11 | Activity | 0 | ALA5256996 | Dose-Dependent Effect | ||||||
11. | ALA302625 | 11 | Activity | 0 | ALA5256995 | Non-Toxic | ||||||
12. | ALA302625 | 11 | Activity | 0 | ALA5256994 | Non-Toxic | ||||||
13. | ALA302625 | 11 | Activity | 0 | ALA5256993 | Non-Toxic | ||||||
14. | ALA302625 | 11 | Activity | > | 90 | % | ALA5256992 | % | ||||
15. | ALA302625 | 11 | Cmax | = | 0.61 | mM | ALA5256990 | nM | ||||
16. | ALA302625 | 11 | IC50 | = | 12 | uM | ALA5256989 | 4.92 | nM | Plasmodium falciparum | ||
17. | ALA302625 | 11 | IC50 | = | 26 | uM | ALA5256988 | 4.58 | nM | Plasmodium falciparum | ||
18. | ALA302625 | 11 | IC50 | = | 9.9 | uM | ALA5256987 | 5.00 | nM | Plasmodium falciparum | ||
19. | ALA302625 | 11 | Ratio IC50 | = | 2 | ALA5256986 | ||||||
20. | ALA302625 | 11 | Ratio IC50 | = | 2 | ALA5256985 |